China Pharma Holdings Inc increased III. Quarter net loss per share of $-0.02 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease compare to $-0.02 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.02
$
2 Mill
Unch.
Unch.-0.64 %
China Pharma Holdings Inc 's Revenue
fell by
-0.64 % in III. Quarter (Sep 30 2022) year on year,
to $2 million and
advanced by
21.87 % sequentially.
China Pharma Holdings Inc is Expected to report next financial results on March 29, 2023.
China Pharma Holdings Inc 's
in III. Quarter recorded net loss of $-0.791 million, an improvement compare to net loss of $-0.827 million in III. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-0.888 million realized in previous quarter.
Inventories declined by -6.08 % to $2.89 million from III. Quarter a year ago, sequentially inventories fell by -18.23 %.
In III. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -39.29%, to $0 millions compare to same quarter a year ago and fell by 44.07% from II. Quarter (Jun 30 2022).
